NeuroBo Pharmaceuticals' Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo's Board of Directors
The NeuroBo Board now consists of seven directors, six of whom are considered independent directors.
- The NeuroBo Board now consists of seven directors, six of whom are considered independent directors.
- "On behalf of the NeuroBo Board, I am delighted to welcome Hyung and Andrew to the Company.
- I look forward to working with NeuroBo's Board and executive management to support the Company's future growth," commented Mr. Kim.
- However, while NeuroBo may elect to update these forward-looking statements at some point in the future, NeuroBo specifically disclaims any obligation to do so.